The global role of STAT3 in the acquisition of a CSC phenotype in ES2 tumorsphere or in a commercially available ovarian cancer-derived CSC (OvCSC) model was further explored in terms of functional chemotactic response to the bioactive JAK/STAT3 inducer lysophosphatidic acid (LPA) [19]. This evidence concerns the gene STAT3 and ovarian carcinoma.